As of April 25, 2025, Benitec Biopharma (BNTC) has a market cap of $0.35 billion USD. According to our data, Benitec Biopharma is ranked No.6369 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 25, 2025 | $0.35 B |
21.06%
|
Dec 31, 2024 | $0.29 B |
291.02%
|
Dec 29, 2023 | $74.99 M |
11.76%
|
Dec 30, 2022 | $67.10 M |
-93.51%
|
Dec 31, 2021 | $1.03 B |
-12.67%
|
Dec 31, 2020 | $1.18 B |
-60.78%
|
Dec 31, 2019 | $3.02 B |
-66.00%
|
Dec 31, 2018 | $8.88 B |
-49.27%
|
Dec 29, 2017 | $17.50 B |
93.46%
|
Dec 30, 2016 | $9.05 B |
-61.94%
|
Dec 31, 2015 | $23.77 B |
-74.16%
|
Dec 31, 2014 | $92.01 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Arrowhead Pharmaceuticals
ARWR
|
$1.83 B |
-0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$31.40 B |
-0.000 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.70 B |
-0.000 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.59 B |
-0.000 M
|
![]() USA
|
![]() BioNTech
BNTX
|
$28.98 B |
0.000 M
|
![]() Germany
|
![]() Editas Medicine
EDIT
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.85 B |
-0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.38 B |
-0.000 M
|
![]() Switzerland
|
![]() Sangamo Therapeutics
SGMO
|
$0.18 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.73 M |
-0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.46 B |
-0.000 M
|
![]() USA
|
![]() Voyager Therapeutics
VYGR
|
$0.19 B |
-0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$2.03 B |
0.000 M
|
![]() USA
|
Market Cap | = | BNTC Stock Price | * | BNTC Shares Outstanding |
= | $13.90 | * | 25.55 M | |
= | $0.35 B |